Background: Peripheral arterial disease (PAD) affects approximately 202 million individuals around the world and is associated with a high risk of myocardial infarction, stroke and death. Although there is a clear inverse association between adult height and the risk of cardiovascular disease, little is known about the relationship between height and PAD. The aim of our study was to assess the relationship between subclinical PAD and height.
Patients And Methods: In a cross-sectional cardiovascular risk factor study in southwestern Finland, ankle brachial index (ABI) and other risk factors were measured from a total of 972 cardiovascular risk subjects derived from the general population. None of them had previously diagnosed diabetes, cardiovascular or renal disease or intermittent claudication. Subjects with an ABI ≤ 0.90 were categorized as having subclinical PAD.
Results: The average age of the study subjects was 58.1 ± 6.7 years for men and 58.8 ± 6.9 years for women. The prevalence of subclinical PAD was 5 % (95 % CI 3 % - 7 %) (23/455) among men and 5 % (95 % CI 3 %-7 %) (26/517) among women. The mean ABI among men and women was 1.09 ± 0.12 and 1.08 ± 0.12, respectively. In men, there was an inverse association between height and the prevalence of subclinical PAD (p < 0.001) along with a positive association between height and ABI values (p < 0.001). In a multivariate model, height, age and current smoking status remained independent factors that were associated with subclinical PAD in men, whereas in women, only pulse pressure was associated with subclinical PAD.
Conclusions: Short stature in men is associated with subclinical PAD and lower ABI values.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1024/0301-1526/a000566 | DOI Listing |
Lymphology
November 2024
UA11 INSERM - UM Institut Desbrest d'Épidémiologie et de Santé Publique (IDESP), Montpellier, France.
Multilayer compression bandaging (MLB) remains the primary treatment in lymphedema in association with manual lymphatic drainage. However, MLB can be contraindicated in patients with advanced lower extremity artery disease (LEAD). Presently, the prevalence of LEAD in lymphedema patients remains unknown.
View Article and Find Full Text PDFMedicina (Kaunas)
September 2024
Internal Medicine Unit, Department of Medicine Specialties, "Pugliese-Ciaccio" Hospital of Catanzaro, Azienda Ospedaliero-Universitaria Renato Dulbecco, Via Pio X n.83, 88100 Catanzaro, Italy.
Vasc Med
December 2024
Gonda Vascular Center, Mayo Clinic, Rochester, MN, USA.
Clin Investig Arterioscler
November 2024
Laboratorio de Aterotrombosis, Programa de Enfermedades Cardiovasculares, Cima Universidad de Navarra, Pamplona, Spain; IdiSNA, Pamplona, Spain; CIBERCV, Madrid, Spain. Electronic address:
Introduction: Despite the key role of the endothelium in atherosclerosis, there are no direct techniques for its analysis. The study of extracellular vesicles of endothelial origin (EEVs), might lead to the identification of molecular signatures and early biomarkers of atherosclerosis. The aim of this work was to set up the methods for EEVs separation and transcriptomic analysis.
View Article and Find Full Text PDFJ Cosmet Dermatol
September 2024
Department of Facial and Cervical Surgery, Plastic Surgery Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!